These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 38098230

  • 1. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity.
    Luan X, Lei T, Fang J, Liu X, Fu H, Li Y, Chu W, Jiang P, Tong C, Qi H, Fu Y.
    Mol Ther; 2024 Feb 07; 32(2):469-489. PubMed ID: 38098230
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
    Marcovecchio PM, Thomas G, Salek-Ardakani S.
    J Immunother Cancer; 2021 Feb 07; 9(2):. PubMed ID: 33637602
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, Todd KL, Henderson MA, Giuffrida L, Petley EV, Sek K, Mardiana S, Gide TN, Quek C, Scolyer RA, Long GV, Wilmott JS, Loi S, Darcy PK, Beavis PA.
    Clin Cancer Res; 2020 Jan 15; 26(2):487-504. PubMed ID: 31636098
    [Abstract] [Full Text] [Related]

  • 9. Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8+ T cell response.
    Kim SH, Cho BH, Kim KS, Jang YS.
    Cell Rep; 2021 Apr 13; 35(2):108995. PubMed ID: 33852847
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer.
    Yuan M, Wang C, Wu Y, Qiao L, Deng G, Liang N, Chen F, Liu L, Chen Y, Yang Y, Wang H, Liu T, Yang X, Zhang Y, Lv Y, Suwinski R, Hu P, Zhang Y, Zhang J.
    Transl Lung Cancer Res; 2023 May 31; 12(5):1093-1107. PubMed ID: 37323177
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.
    Imamura R, Kitagawa S, Kubo T, Irie A, Kariu T, Yoneda M, Kamba T, Imamura T.
    Prostate; 2021 Feb 31; 81(3):147-156. PubMed ID: 33368414
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
    Ma S, Sun B, Duan S, Han J, Barr T, Zhang J, Bissonnette MB, Kortylewski M, He C, Chen J, Caligiuri MA, Yu J.
    Nat Immunol; 2023 Feb 31; 24(2):255-266. PubMed ID: 36658237
    [Abstract] [Full Text] [Related]

  • 16. Blockade of DC-SIGN+ Tumor-Associated Macrophages Reactivates Antitumor Immunity and Improves Immunotherapy in Muscle-Invasive Bladder Cancer.
    Hu B, Wang Z, Zeng H, Qi Y, Chen Y, Wang T, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Dai B, Guo J, Xu L, Zhang W, Xu J.
    Cancer Res; 2020 Apr 15; 80(8):1707-1719. PubMed ID: 32060149
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
    Zhang P, Gu Y, Wang J, Lv K, Lin C, Zhang H, Li H, He H, Li R, Liu H, Xu J.
    Int J Cancer; 2023 Jul 01; 153(1):224-237. PubMed ID: 36799619
    [Abstract] [Full Text] [Related]

  • 19. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
    Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L, Manne S, Fairlie DP, Gorczyca W, Almanza O, Karbowniczek M, Markiewski MM.
    Cancer Res; 2014 Jul 01; 74(13):3454-65. PubMed ID: 24786787
    [Abstract] [Full Text] [Related]

  • 20. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S, Nagata H, Crosby EJ, Inoue Y, Kaneko K, Liu CX, Yang X, Wang T, Acharya CR, Agarwal P, Snyder J, Gwin W, Morse MA, Zhong P, Lyerly HK, Osada T.
    J Immunother Cancer; 2022 Jan 01; 10(1):. PubMed ID: 35039461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.